Investors finally get a glimpse of Tonix Pharmaceuticals Holding Corp (TNXP) volume hitting the figure of 1.5 million.

A new trading day began on Friday, with Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) stock price up 9.58% from the previous day of trading, before settling in for the closing price of $26.40. TNXP’s price has ranged from $6.76 to $624.00 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 5.99% over the past five years. Meanwhile, its annual earnings per share averaged 92.98%. With a float of $7.32 million, this company’s outstanding shares have now reached $7.32 million.

Let’s look at the performance matrix of the company that is accounted for 81 employees. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.

Tonix Pharmaceuticals Holding Corp (TNXP) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.78%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.

Tonix Pharmaceuticals Holding Corp (TNXP) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 92.98% per share during the next fiscal year.

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators

Here are Tonix Pharmaceuticals Holding Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.11.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -32.12, a number that is poised to hit -2.92 in the next quarter and is forecasted to reach -4.67 in one year’s time.

Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw its 5-day average volume 2.01 million, a positive change from its year-to-date volume of 1.4 million. As of the previous 9 days, the stock’s Stochastic %D was 66.01%. Additionally, its Average True Range was 3.05.

During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 43.02%, which indicates a significant decrease from 73.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.55% in the past 14 days, which was lower than the 213.58% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $20.12, while its 200-day Moving Average is $21.54. Nevertheless, the first resistance level for the watch stands at $30.08 in the near term. At $31.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $33.27. If the price goes on to break the first support level at $26.89, it is likely to go to the next support level at $24.86. The third support level lies at $23.70 if the price breaches the second support level.

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats

With a market capitalization of 211.90 million, the company has a total of 7,325K Shares Outstanding. Currently, annual sales are 10,090 K while annual income is -130,040 K. The company’s previous quarter sales were 2,430 K while its latest quarter income was -16,830 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.